ATLASExagen (XGN) earnings date: Nov 10, 2026
Exagen (XGN) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 10, 2026, before the open. Analysts expect EPS of -$0.19.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on XGN
| Last price | $8.59 (-1.3%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.0% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Exagen stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Exagen reports on Nov 10, 2026. One email the day before, with ATLAS’s read on Exagen. You can switch it off at any time.
Alert me before XGN reportsFree to start. Creating an account takes under a minute.
Notify me when Exagen reports
XGN earnings at a glance
| Next report (confirmed) | Tue, Nov 10, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.19 |
| Last report | Aug 4, 2026 · Beat |
| Beat rate (last 4 reports) | 2 of 4 (50%) |
| Average EPS surprise | -23.5% |
| Average move around a report | ±16.9% (last 4) |
| Sector | Healthcare · Diagnostics & Research |
Exagen earnings history: last 4 reports
Exagen last reported on Aug 4, 2026: EPS of -$0.11 against an estimate of -$0.17 (+35.3% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 4, 2026 | -$0.17 | -$0.11 | +35.3% | Beat | +42.1% |
| May 6, 2026 | $2.55 | $2.72 | +6.7% | Beat | -4.9% |
| Mar 10, 2026 | -$0.19 | -$0.27 | -42.1% | Miss | -8.0% |
| Nov 4, 2025 | -$0.16 | -$0.31 | -93.8% | Miss | -12.7% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for XGN
See the fair value, the probability range and the earnings history of Exagen on its ATLAS page.
Exagen (XGN) stock analysisPlans from €3.99 a month.
Exagen earnings: frequently asked questions
When does Exagen (XGN) report earnings?
Exagen is scheduled to report on Tuesday, November 10, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for XGN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.19 per share (USD). Estimates can change before the report.
How often does XGN beat earnings estimates?
Of its last 4 reports with a recorded result, Exagen beat the EPS estimate 2 times; the average surprise was -23.5%. Past results do not predict the next one.
How much does XGN move around earnings?
Over its last 4 reports the stock moved an average of 16.9% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Exagen beat earnings estimates last quarter?
Exagen last reported on Aug 4, 2026: EPS of -$0.11 against an estimate of -$0.17 (+35.3% surprise), a beat.
How much does XGN usually move in a day?
On a normal trading day the ATLAS model puts XGN’s one-day range at about ±4.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 10, 2026
Educational information, not investment advice. Disclaimer